ATE362531T1 - Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung - Google Patents

Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung

Info

Publication number
ATE362531T1
ATE362531T1 AT00906237T AT00906237T ATE362531T1 AT E362531 T1 ATE362531 T1 AT E362531T1 AT 00906237 T AT00906237 T AT 00906237T AT 00906237 T AT00906237 T AT 00906237T AT E362531 T1 ATE362531 T1 AT E362531T1
Authority
AT
Austria
Prior art keywords
ires
mrna
internal ribosome
ribosome entry
vector
Prior art date
Application number
AT00906237T
Other languages
English (en)
Inventor
Sigrid Cornelis
Rudi Beyaert
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of ATE362531T1 publication Critical patent/ATE362531T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00906237T 1999-01-26 2000-01-26 Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung ATE362531T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200216 1999-01-26

Publications (1)

Publication Number Publication Date
ATE362531T1 true ATE362531T1 (de) 2007-06-15

Family

ID=8239831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906237T ATE362531T1 (de) 1999-01-26 2000-01-26 Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung

Country Status (6)

Country Link
EP (1) EP1147188B1 (de)
AT (1) ATE362531T1 (de)
AU (1) AU775750B2 (de)
CA (1) CA2357709A1 (de)
DE (1) DE60034874T2 (de)
WO (1) WO2000044896A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224403A1 (en) * 2000-10-13 2002-04-22 Entremed, Inc Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
CA2708766C (en) * 2007-12-11 2016-02-02 The Scripps Research Institute Compositions and methods related to mrna translational enhancer elements
AU2013201458B2 (en) * 2007-12-11 2014-10-02 The Scripps Research Institute COMPOSITIONS AND METHODS RELATED TO mRNA TRANSLATIONAL ENHANCER ELEMENTS
WO2012056441A1 (en) * 2010-10-28 2012-05-03 Nanodoc Ltd. Compositions and methods for specific cleavage of exogenous rna in a cell

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942969A1 (de) * 1996-11-12 1999-09-22 Qbi Enterprises Ltd. Verfahren zur identifizierung von genen welche auf der stufe der translation reguliert werden

Also Published As

Publication number Publication date
DE60034874T2 (de) 2008-01-24
CA2357709A1 (en) 2000-08-03
AU2799200A (en) 2000-08-18
WO2000044896A1 (en) 2000-08-03
EP1147188A1 (de) 2001-10-24
AU775750B2 (en) 2004-08-12
EP1147188B1 (de) 2007-05-16
DE60034874D1 (de) 2007-06-28

Similar Documents

Publication Publication Date Title
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
WO2003103589A3 (en) USE OF IL-21 IN THE TREATMENT OF CANCER AND OTHER THERAPEUTIC APPLICATIONS
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
MY104909A (en) Peptide compounds.
ATE362531T1 (de) Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung
DE60008077D1 (de) Matrixprotein zusammensetzungen um apoptose zu induzieren
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
DE58907373D1 (de) Modifizierte Proteine.
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
ATE332923T1 (de) Cr1 fragmente und deren verwendung
PT1103270E (pt) Tratamento de doencas auto-imunes em mamiferos
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties